| Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ... Science 354 (6313), 751-757, 2016 | 539 | 2016 |
| Stepwise pathogenic evolution of Mycobacterium abscessus JM Bryant, KP Brown, S Burbaud, I Everall, JM Belardinelli, ... Science 372 (6541), eabb8699, 2021 | 109 | 2021 |
| Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections TH Brandon Banaschewski, Deepshikha Verma, Lian J. Penningsc, Matthew ... Journal of Cystic Fibrosis, https://doi.org/10.1016/j.jcf.2019.05.01, 2019 | 53* | 2019 |
| The efficacy of the BCG vaccine against newly emerging clinical strains of Mycobacterium tuberculosis M Henao-Tamayo, CA Shanley, D Verma, A Zilavy, MC Stapleton, ... PLoS One 10 (9), e0136500, 2015 | 43 | 2015 |
| Truncated hemoglobin, HbN, is post-translationally modified in Mycobacterium tuberculosis and modulates host-pathogen interactions during intracellular infection S Arya, D Sethi, S Singh, MD Hade, V Singh, P Raju, SB Chodisetti, ... Journal of Biological Chemistry 288 (41), 29987-29999, 2013 | 38 | 2013 |
| Mycobacterium avium infection in a C3HeB/FeJ mouse model D Verma, M Stapleton, J Gadwa, K Vongtongsalee, AR Schenkel, ... Frontiers in microbiology 10, 410848, 2019 | 21 | 2019 |
| Epidemiologic Evidence of and Potential Mechanisms by Which Second-Hand Smoke Causes Predisposition to Latent and Active Tuberculosis X Bai, SL Aerts, D Verma, DJ Ordway, ED Chan Immune Network 18 (10.4110/in.2018.18.e22), 1-19, 2018 | 20 | 2018 |
| Secretory nucleoside diphosphate kinases from both intra-and extracellular pathogenic bacteria are functionally indistinguishable HH Dar, D Prasad, GC Varshney, PK Chakraborti Microbiology 157 (11), 3024-3035, 2011 | 20 | 2011 |
| Population-level genomics identifies the emergence and global spread of a human transmissible multidrug-resistant nontuberculous mycobacterium JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ... Science (New York, NY) 354 (6313), 751, 2016 | 17 | 2016 |
| Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus JM Belardinelli, D Verma, W Li, C Avanzi, CJ Wiersma, JT Williams, ... Science translational medicine 14 (633), eabj3860, 2022 | 15 | 2022 |
| Cell Surface Remodeling of Mycobacterium abscessus under Cystic Fibrosis Airway Growth Conditions CJ Wiersma, JM Belardinelli, C Avanzi, SK Angala, I Everall, B Angala, ... ACS Infectious Diseases 6 (8), 2143-2154, 2020 | 14 | 2020 |
| Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission CA Shanley, MI Henao-Tamayo, C Bipin, R Mugasimangalam, D Verma, ... Tuberculosis 109, 123-133, 2018 | 14 | 2018 |
| Non-tuberculous mycobacteria interference with BCG-current controversies and future directions D Verma, ED Chan, DJ Ordway Vaccines 8 (4), 688, 2020 | 12 | 2020 |
| Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs RJ Chandak, B Malhotra, S Bhargava, SK Goel, D Verma, J Tiwari The International Journal of Tuberculosis and Lung Disease 23 (12), 1257-1262, 2019 | 10 | 2019 |
| Stepwise pathogenic evolution of Mycobacterium abscessus. Science 372: eabb8699 JM Bryant, KP Brown, S Burbaud, I Everall, JM Belardinelli, ... | 9 | 2021 |
| Animal models of Mycobacteria infection ED Chan, D Verma, DJ Ordway Current Protocols in Immunology 129 (1), e98, 2020 | 9 | 2020 |
| Microscopic study of zinc nanoparticles synthesised using thermosetting polymer G Tailor, J Chaudhay, D Verma, B Kr. Sarma Applied Microscopy 49, 1-5, 2019 | 9 | 2019 |
| Borrelia burgdorferi BBI39 Paralogs, Targets of Protective Immunity, Reduce Pathogen Persistence Either in Hosts or in the Vector P Singh, D Verma, BT Backstedt, S Kaur, M Kumar, AA Smith, K Sharma, ... The Journal of Infectious Diseases 215 (6), 1000-1009, 2017 | 9 | 2017 |
| Apramycin overcomes the inherent lack of antimicrobial bactericidal activity in Mycobacterium abscessus P Selchow, DJ Ordway, D Verma, N Whittel, A Petrig, SN Hobbie, ... Antimicrobial Agents and Chemotherapy 66 (2), e01510-21, 2022 | 8 | 2022 |
| Nanoluciferase reporter mycobacteriophage for sensitive and rapid detection of Mycobacterium tuberculosis drug susceptibility P Jain, S Garing, D Verma, R Saranathan, N Clute-Reinig, J Gadwa, ... Journal of Bacteriology 202 (22), 10.1128/jb. 00411-20, 2020 | 8 | 2020 |
Diane OrdwayInfectious Disease, Colorado State University在 colostate.edu 的电子邮件经过验证
